Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 August 2022 | Story Samkelo Fetile | Photo Charl Devenish
Gadija Brown MEC for Finance in the Free State
Gadija Brown, Free State MEC for Finance.

Students in the Department of Business Management within the Faculty of Economic and Management Sciences at the University of the Free State (UFS) had the opportunity to attend guest lectures by Gadija Brown, MEC for Finance, and Makalo Mohale, MEC for Economic, Small Business Development, Tourism, and Environmental Affairs (DESTEA) in the Free State government. The guest lectures, which took place on 1 August 2022, were also attended by the Black Management Forum (BMF) Free State Chapter Chair, Mosebetsi Dladla. 

Insights from the guest lecturers

“A priority for the government was SMEs involved in agriculture, tourism, and agricultural industrialisation or manufacturing, as these were the main contributors to the Free State’s economy,” said Brown in her keynote address as she profiled the small business sector of the Free State. 
Makalo Mohale discussed the importance of establishing an enabling environment for the creation of SMEs in the province. “University students, such as the UFS students, can be active participants in the economy by creating businesses that are feasible and viable in order to reduce the unemployment rate of the country, as well as provide employment for themselves,” he said.

Prof Brownhilder Neneh, Head of the Department of Business Management, extended her gratitude to the Free State government representatives for honouring the invitation. She advocated for more interactions and partnerships between the university and provincial government to create a synergy of collaborations between government and academia.

Makalo Mohale MEC Economic, Small Business Development, Tourism, and Environmental Affairs
Makalo Mohale. Photo: Supplied. 


From sit-down exam to practical engagement

The Department of Business Management offers Small Business Management as an undergraduate programme at NQF Level 7 (16 credits) during the third year of study. The module's goal is to give students the knowledge and abilities they need to become capable and self-assured business professionals or leaders.
Dr Ekaete Benedict, Coordinator of the Entrepreneurship and Small Business Management modules, outlined that the group project is what students are assessed on, instead of a sit-down examination. 

“One of the first things I did to change the curricula of the module was to apply for it to become a continuous assessment module,” she said.  “That is, do away with the sit down and write exam component at the end of the semester, and rather test the students on practical engagement with real-life business scenarios and people throughout the duration of the semester,” she continued. 

“This is in line with best practices at the world's top universities,” Dr Benedict concluded.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept